# United Parks & Resorts Inc.: financial statements, quarterly

PRKS · NYSE · CIK 1564902 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prks.md) · [Financials](/companies/prks/financials.md) · [Filings](/companies/prks/filings.md) · [Insiders](/companies/prks/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prks/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [548](/filings/0000950170-24-123690.md) | [389 d](/filings/0001193125-26-088288.md) | [297](/filings/0000950170-25-069292.md) | [498](/filings/0000950170-25-105467.md) | [546](/filings/0001193125-25-271018.md) | [384 d](/filings/0001193125-26-088288.md) | [287](/filings/0001193125-26-217005.md) | [490](/filings/0001193125-26-340383.md) | [512](/filings/0001193125-25-271018.md) | [374 d](/filings/0001193125-26-088288.md) | [278](/filings/0001193125-26-217005.md) | [483](/filings/0001193125-26-340383.md) |
| Selling, general and administrative | $m | [59.7](/filings/0000950170-24-123690.md) | [45.1 d](/filings/0001193125-26-088288.md) | [47.9](/filings/0000950170-25-069292.md) | [63.8](/filings/0000950170-25-105467.md) | [55.4](/filings/0001193125-25-271018.md) | [49.9 d](/filings/0001193125-26-088288.md) | [44.1](/filings/0001193125-26-217005.md) | [64.4](/filings/0001193125-26-340383.md) | [60.7](/filings/0001193125-25-271018.md) | [58.6 d](/filings/0001193125-26-088288.md) | [48.1](/filings/0001193125-26-217005.md) | [66.6](/filings/0001193125-26-340383.md) |
| Operating income | $m | [203](/filings/0000950170-24-123690.md) | [89.3 d](/filings/0001193125-26-088288.md) | [22.1](/filings/0000950170-25-069292.md) | [164](/filings/0000950170-25-105467.md) | [201](/filings/0001193125-25-271018.md) | [75.8 d](/filings/0001193125-26-088288.md) | [16.9](/filings/0001193125-26-217005.md) | [140](/filings/0001193125-26-340383.md) | [152](/filings/0001193125-25-271018.md) | [56.4 d](/filings/0001193125-26-088288.md) | [(8.5)](/filings/0001193125-26-217005.md) | [117](/filings/0001193125-26-340383.md) |
| Interest expense | $m | [37.1](/filings/0000950170-24-123690.md) | [36.3 d](/filings/0001193125-26-088288.md) | [38.8](/filings/0000950170-25-069292.md) | [39.4](/filings/0000950170-25-105467.md) | [39.7](/filings/0001193125-25-271018.md) | [49.9 d](/filings/0001193125-26-088288.md) | [34.1](/filings/0001193125-26-217005.md) | [34.0](/filings/0001193125-26-340383.md) | [33.5](/filings/0001193125-25-271018.md) | [32.6 d](/filings/0001193125-26-088288.md) | [31.7](/filings/0001193125-26-217005.md) | [32.4](/filings/0001193125-26-340383.md) |
| Income tax | $m | [42.7](/filings/0000950170-24-123690.md) | [13.0 d](/filings/0001193125-26-088288.md) | [(5.6)](/filings/0000950170-25-069292.md) | [31.6](/filings/0000950170-25-105467.md) | [41.6](/filings/0001193125-25-271018.md) | [(3.5) d](/filings/0001193125-26-088288.md) | [(1.1)](/filings/0001193125-26-217005.md) | [26.2](/filings/0001193125-26-340383.md) | [29.0](/filings/0001193125-25-271018.md) | [4.0 d](/filings/0001193125-26-088288.md) | [(5.9)](/filings/0001193125-26-217005.md) | [21.4](/filings/0001193125-26-340383.md) |
| Net income | $m | [124](/filings/0000950170-24-123690.md) | [40.1 d](/filings/0001193125-26-088288.md) | [(11.2)](/filings/0001193125-25-271018.md) | [91.1](/filings/0001193125-25-271018.md) | [120](/filings/0001193125-25-271018.md) | [27.9 d](/filings/0001193125-26-088288.md) | [(16.1)](/filings/0001193125-26-340383.md) | [80.1](/filings/0001193125-26-340383.md) | [89.3](/filings/0001193125-25-271018.md) | [15.1 d](/filings/0001193125-26-088288.md) | [(34.1)](/filings/0001193125-26-340383.md) | [63.3](/filings/0001193125-26-340383.md) |
| Diluted EPS | $ per share | [1.92](/filings/0000950170-24-123690.md) | not reported | [(0.17)](/filings/0000950170-25-069292.md) | [1.46](/filings/0000950170-25-105467.md) | [2.08](/filings/0001193125-25-271018.md) | not reported | [(0.29)](/filings/0001193125-26-217005.md) | [1.45](/filings/0001193125-26-340383.md) | [1.61](/filings/0001193125-25-271018.md) | not reported | [(0.69)](/filings/0001193125-26-217005.md) | [1.34](/filings/0001193125-26-340383.md) |
| Basic EPS | $ per share | [1.93](/filings/0000950170-24-123690.md) | not reported | [(0.17)](/filings/0000950170-25-069292.md) | [1.47](/filings/0000950170-25-105467.md) | [2.09](/filings/0001193125-25-271018.md) | not reported | [(0.29)](/filings/0001193125-26-217005.md) | [1.46](/filings/0001193125-26-340383.md) | [1.62](/filings/0001193125-25-271018.md) | not reported | [(0.69)](/filings/0001193125-26-217005.md) | [1.36](/filings/0001193125-26-340383.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [215](/filings/0000950170-23-061536.md) | [247](/filings/0000950170-25-030398.md) | [204](/filings/0000950170-24-057103.md) | [232](/filings/0000950170-24-093331.md) | [76.8](/filings/0000950170-24-123690.md) | [116](/filings/0001193125-26-088288.md) | [75.7](/filings/0000950170-25-069292.md) | [194](/filings/0000950170-25-105467.md) | [183](/filings/0001193125-25-271018.md) | [99.8](/filings/0001193125-26-340383.md) | [28.9](/filings/0001193125-26-217005.md) | [19.1](/filings/0001193125-26-340383.md) |
| Current assets | $m | [376](/filings/0000950170-23-061536.md) | [390](/filings/0000950170-25-030398.md) | [377](/filings/0000950170-24-057103.md) | [431](/filings/0000950170-24-093331.md) | [256](/filings/0000950170-24-123690.md) | [270](/filings/0001193125-26-088288.md) | [256](/filings/0000950170-25-069292.md) | [399](/filings/0000950170-25-105467.md) | [407](/filings/0001193125-25-271018.md) | [283](/filings/0001193125-26-340383.md) | [241](/filings/0001193125-26-217005.md) | [244](/filings/0001193125-26-340383.md) |
| Total assets | $m | [2,576](/filings/0000950170-23-061536.md) | [2,625](/filings/0000950170-25-030398.md) | [2,669](/filings/0000950170-24-057103.md) | [2,757](/filings/0000950170-24-093331.md) | [2,580](/filings/0000950170-24-123690.md) | [2,574](/filings/0001193125-26-088288.md) | [2,571](/filings/0000950170-25-069292.md) | [2,730](/filings/0000950170-25-105467.md) | [2,740](/filings/0001193125-25-271018.md) | [2,616](/filings/0001193125-26-340383.md) | [2,608](/filings/0001193125-26-217005.md) | [2,641](/filings/0001193125-26-340383.md) |
| Current liabilities | $m | [406](/filings/0000950170-23-061536.md) | [411](/filings/0000950170-25-030398.md) | [490](/filings/0000950170-24-057103.md) | [523](/filings/0000950170-24-093331.md) | [398](/filings/0000950170-24-123690.md) | [413](/filings/0001193125-26-088288.md) | [435](/filings/0000950170-25-069292.md) | [483](/filings/0000950170-25-105467.md) | [375](/filings/0001193125-25-271018.md) | [385](/filings/0001193125-26-340383.md) | [455](/filings/0001193125-26-217005.md) | [510](/filings/0001193125-26-340383.md) |
| Total liabilities | $m | [2,828](/filings/0000950170-23-061536.md) | [2,833](/filings/0000950170-25-030398.md) | [2,912](/filings/0000950170-24-057103.md) | [3,122](/filings/0000950170-24-093331.md) | [3,035](/filings/0000950170-24-123690.md) | [3,035](/filings/0001193125-26-088288.md) | [3,049](/filings/0000950170-25-069292.md) | [3,125](/filings/0000950170-25-105467.md) | [3,049](/filings/0001193125-25-271018.md) | [3,052](/filings/0001193125-26-340383.md) | [3,165](/filings/0001193125-26-217005.md) | [3,259](/filings/0001193125-26-340383.md) |
| Long-term debt | $m | [2,095](/filings/0000950170-23-061536.md) | [2,093](/filings/0000950170-25-030398.md) | [2,092](/filings/0000950170-24-057103.md) | [2,240](/filings/0000950170-24-093331.md) | [2,235](/filings/0000950170-24-123690.md) | [2,229](/filings/0001193125-26-088288.md) | [2,226](/filings/0000950170-25-069292.md) | [2,223](/filings/0000950170-25-105467.md) | [2,220](/filings/0001193125-25-271018.md) | [2,218](/filings/0001193125-26-340383.md) | [2,245](/filings/0001193125-26-217005.md) | [2,262](/filings/0001193125-26-340383.md) |
| Current portion of debt | $m | [12.0](/filings/0000950170-23-061536.md) | [12.0](/filings/0000950170-25-030398.md) | [11.7](/filings/0000950170-24-057103.md) | [15.5](/filings/0000950170-24-093331.md) | [15.5](/filings/0000950170-24-123690.md) | [15.4](/filings/0001193125-26-088288.md) | [15.4](/filings/0000950170-25-069292.md) | [15.4](/filings/0000950170-25-105467.md) | [15.4](/filings/0001193125-25-271018.md) | [15.4](/filings/0001193125-26-340383.md) | [15.4](/filings/0001193125-26-217005.md) | [15.4](/filings/0001193125-26-340383.md) |
| Shareholders' equity | $m | [(252)](/filings/0000950170-24-123690.md) | [(208)](/filings/0001193125-26-088288.md) | [(243)](/filings/0001193125-25-271018.md) | [(365)](/filings/0001193125-25-271018.md) | [(456)](/filings/0001193125-25-271018.md) | [(462)](/filings/0001193125-26-340383.md) | [(478)](/filings/0001193125-26-340383.md) | [(395)](/filings/0001193125-26-340383.md) | [(309)](/filings/0001193125-25-271018.md) | [(436)](/filings/0001193125-26-340383.md) | [(557)](/filings/0001193125-26-340383.md) | [(617)](/filings/0001193125-26-340383.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [164 d](/filings/0000950170-24-123690.md) | [106 d](/filings/0001193125-26-088288.md) | [71.4](/filings/0000950170-25-069292.md) | [173 d](/filings/0000950170-25-105467.md) | [123 d](/filings/0001193125-25-271018.md) | [112 d](/filings/0001193125-26-088288.md) | [25.7](/filings/0001193125-26-217005.md) | [181 d](/filings/0001193125-26-340383.md) | [94.8 d](/filings/0001193125-25-271018.md) | [78.4 d](/filings/0001193125-26-088288.md) | [66.8](/filings/0001193125-26-217005.md) | [170 d](/filings/0001193125-26-340383.md) |
| Capital expenditure | $m | [88.6 d](/filings/0000950170-24-123690.md) | [70.6 d](/filings/0001193125-26-088288.md) | [87.3](/filings/0000950170-25-069292.md) | [79.5 d](/filings/0000950170-25-105467.md) | [55.4 d](/filings/0001193125-25-271018.md) | [26.2 d](/filings/0001193125-26-088288.md) | [56.9](/filings/0001193125-26-217005.md) | [53.6 d](/filings/0001193125-26-340383.md) | [56.8 d](/filings/0001193125-25-271018.md) | [50.3 d](/filings/0001193125-26-088288.md) | [69.6](/filings/0001193125-26-217005.md) | [68.6 d](/filings/0001193125-26-340383.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [3.9 d](/filings/0000950170-24-123690.md) | [0.0 d](/filings/0001193125-26-088288.md) | [16.9](/filings/0000950170-25-069292.md) | [212 d](/filings/0000950170-25-105467.md) | [216 d](/filings/0001193125-25-271018.md) | [37.7 d](/filings/0001193125-26-088288.md) | [4.6](/filings/0001193125-26-217005.md) | [4.6 d](/filings/0001193125-26-340383.md) | [7.1 d](/filings/0001193125-25-271018.md) | [144 d](/filings/0001193125-26-088288.md) | [93.8](/filings/0001193125-26-217005.md) | [126 d](/filings/0001193125-26-340383.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.6](/filings/0000950170-23-061536.md) | [64.0](/filings/0000950170-24-057103.md) | [64.4](/filings/0000950170-24-093331.md) | [64.3](/filings/0000950170-24-123690.md) | [64.0](/filings/0000950170-25-069292.md) | [62.3](/filings/0000950170-25-105467.md) | [57.7](/filings/0001193125-25-271018.md) | [55.0](/filings/0001193125-26-217005.md) | [55.4](/filings/0001193125-26-340383.md) | [55.5](/filings/0001193125-25-271018.md) | [49.4](/filings/0001193125-26-217005.md) | [47.2](/filings/0001193125-26-340383.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 45,341,309 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340383.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.